The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers

被引:38
作者
Buttini, Francesca [1 ]
Rozou, Stavroula [2 ]
Rossi, Alessandra [1 ]
Zoumpliou, Varvara [2 ]
Rekkas, Dimitrios M. [3 ]
机构
[1] Univ Parma, Food & Drug Dept, Parco Area Sci 27-A, I-43124 Parma, Italy
[2] ELPEN Pharmaceut Co Inc, 95 Marathonos Ave, Pikermi 19009, Attica, Greece
[3] Univ Athens, Dept Pharm, Athens 15784, Greece
关键词
Quality by Design; Dry powder inhalers; Orally inhaled drug products; Design of Experiments; Risk analysis; System thinking; VITRO AERODYNAMIC PERFORMANCE; PROCESS ANALYTICAL TECHNOLOGY; CRITICAL MATERIAL ATTRIBUTES; CYSTIC-FIBROSIS PATIENTS; INHALATION FORMULATION; RAMAN-SPECTROSCOPY; PARTICLE FORMATION; DELIVERY; PRODUCT; ASTHMA;
D O I
10.1016/j.ejps.2017.10.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review aims in discussing the application of the Quality by Design (QbD) approach on the development of the Dry Powders Inhalers (DPIs). It starts with a thorough presentation of the Quality's concept evolution within the pharmaceutical sector and how this slowly adopted set of quality guidelines is now a major scientific and regulatory requirement. DPIs represent a type of delivery system where the system's thinking approach integrating the device, the formulation and the patient represent a major challenge to be met. Within this context this review points out the critical gaps in this optimization exercise and proposes a series of remedies in overcoming the obstacles when the system's parts are viewed alone and not as a whole. Statistical thinking and the corresponding tools are the means for successfully carrying out this purpose. QbD is not just another guideline to simply comply with. It is the ultimate scope of any pharmaceutical development effort, which is to fully understand and then consistently meet the patient's needs during the entire lifecycle of the product. QbD is focusing on delivering quality value to the patients without compromises in product's safety and effectiveness profile.
引用
收藏
页码:64 / 76
页数:13
相关论文
共 61 条
  • [1] Adams Wallace P, 2010, J Aerosol Med Pulm Drug Deliv, V23, P1, DOI 10.1089/jamp.2009.0803
  • [2] [Anonymous], 2003, AAPS PHARMSCITECH, DOI DOI 10.1208/PT040227
  • [3] Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice
    Azouz, Wahida
    Chrystyn, Henry
    [J]. PRIMARY CARE RESPIRATORY JOURNAL, 2012, 21 (02): : 208 - 213
  • [4] Balducci AG, 2015, PULMONARY DRUG DELIV, P241
  • [5] Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation
    Belotti, Silvia
    Rossi, Alessandra
    Colombo, Paolo
    Bettini, Ruggero
    Rekkas, Dimitrios
    Politis, Stavros
    Colombo, Gaia
    Balducci, Anna Giulia
    Buttini, Francesca
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 93 : 165 - 172
  • [6] Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction
    Belotti, Silvia
    Rossi, Alessandra
    Colombo, Paolo
    Bettini, Ruggero
    Rekkas, Dimitrios
    Politis, Stavros
    Colombo, Gaia
    Balducci, Anna Giulia
    Buttini, Francesca
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 471 (1-2) : 507 - 515
  • [7] ON THE EXPERIMENTAL ATTAINMENT OF OPTIMUM CONDITIONS
    BOX, GEP
    WILSON, KB
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1951, 13 (01) : 1 - 45
  • [8] Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder Inhalers
    Buttini, Francesca
    Brambilla, Gaetano
    Copelli, Diego
    Sisti, Viviana
    Balducci, Anna Giulia
    Bettini, Ruggero
    Pasquali, Irene
    [J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2016, 29 (02) : 167 - 178
  • [9] Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler
    Buttini, Francesca
    Pasquali, Irene
    Brambilla, Gaetano
    Copelli, Diego
    Alberi, Massimiliano Dagli
    Balducci, Anna Giulia
    Bettini, Ruggero
    Sisti, Viviana
    [J]. PHARMACEUTICAL RESEARCH, 2016, 33 (03) : 701 - 715
  • [10] Cantarelli A. M., 2010, RESP DRUG DELIV, V2010, P503